FDA Announces Proposed Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration has submitted a proposed collection of information to the Office of Management and Budget for review and clearance, focusing on Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components, as well as Requirements for Donation Testing, Donor Notification, and 'Lookback'.